Global Health Hub: Ketamine is an essential medicine: an update from the frontline
Jason Nickerson, a clinical scientist with the Bruyère Research Institute, discusses a Chinese proposal to the U.N. Commission on Narcotic Drugs to place “restrictive controls” on ketamine, an anesthetic used in many low-resource settings. He writes, “…While this campaign will hopefully be a win for ketamine, this system continues to deprive billions of people of access to essential medicines, and that has to change. We should not forget why we are fighting this: these systems are broken…” (3/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.